Carregant...

Bismaleimide cross‐linked anthrax toxin forms functional octamers with high specificity in tumor targeting

In recent years, anthrax toxin has been reengineered to act as a highly specific antiangiogenic cancer therapeutic, shown to kill tumors in animal models. This has been achieved by modifying protective antigen (PA) so that its activation and toxicity require the presence of two proteases, matrix met...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Protein Sci
Autors principals: Fischer, Elyse S., Campbell, Warren A., Liu, Shihui, Ghirlando, Rodolfo, Fattah, Rasem J., Bugge, Thomas H., Leppla, Stephen H.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511737/
https://ncbi.nlm.nih.gov/pubmed/30942916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pro.3613
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!